Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

Phase 1, Randomized, Open-label, Single center study to evaluate Pharmacokinetic and Bioequivalence of Levonorgestrel Vaginal Delivery Syste… Recruiting

2025-524330-25-00 No medical condition 2026-04-21
A study in healthy people to test how vicadrostat affects the heart Recruiting

2025-524106-14-00 Healthy volunteer trial 2026-04-20
Mass Balance Study of [14C] ABBV-932 in Healthy Male Volunteers Recruiting

2024-514454-75-00 Healthy Volunteers 2026-04-16
Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health Recruiting

2025-522920-28-00 Obesity, CCI, CCI 2026-04-10
A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people Recruiting

2025-525025-12-00 Iron overload from thalassemia, transfusion-dependent m 2026-04-10
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up into the Blood of Healthy Adults After Taking Different Tablets of t… Recruiting

2025-525041-43-00 Coronavirus disease 2019 2026-04-07
A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women Recruiting

2026-525208-90-00 Multiple sclerosis 2026-04-01
An Open-Label, Single-Arm Phase 1 Trial to Evaluate The Safety, Tolerability and Efficacy of Vididencel in Chronic Phase Chronic Myeloid Leu… Recruiting

2025-524587-37-00 Chronic Phase Chronic Myeloid Leukemia 2026-03-31
A clinical trial of MK-7228 in adults (MK-7228-002) Recruiting

2025-522147-18-00 Atherosclerosis 2026-03-30
Peri-operative intraperitoneal irinotecan and systemic FLOT in the curative treatment of gastric cancer and gastroesophageal junction cancer… Recruiting

2025-522864-34-00 Gastric cancer 2026-03-30
Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes Recruiting

2025-521595-55-00 Type 2 Diabetes 2026-03-25
A research study looking at how NNC0487-0111 affects food intake, appetite and metabolism after meals in people with obesity Recruiting

2025-521393-34-00 Participants with obesity, but otherwise healthy 2026-03-19
A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of … Recruiting

2025-524172-29-00 Healthy volunteers 2026-03-18
A clinical trial of MK-6916 in healthy participants (MK-6916-010) Recruiting

2025-524570-41-00 Acute and Chronic pain 2026-03-16
A study investigating the safety, absorption, and elimination of RO7795068, a new compound that may potentially be used in the treatment of … Recruiting

2025-524856-73-00 Not Applicable 2026-03-13
A Phase 1 study to evaluate the effect of BV100 on the pharmacokinetics of polymyxin B in healthy volunteers Recruiting

2025-521020-30-00 Healthy volunteer trial. Intended indication: treatment 2026-03-12
A study to see how a single increasing dose of the oral drug AD-700 affects the ability of a CT scan to detect activated brown fat in health… Recruiting

2025-520584-41-00 Metabolism dysfunction 2026-03-10
CLonE-specific CAR T-Cell therapy in relapsed or refractory AL amyloidosis - a single-center Phase I trial (CLEAR AL) Recruiting

2025-520790-39-00 relapsed or refractory AL amyloidosis 2026-03-04
Safety, Tolerability and Efficacy against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults Recruiting

2024-518273-34-02 Malaria 2026-03-02
Early-stage clinical trial investigating the individual and combined effect of two drugs, senicapoc and perampanel, as part of the treatment… Recruiting

2025-522605-37-00 Glioblastoma 2026-03-01
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants with Advanced Solid Tumors Previo… Recruiting

2025-521614-26-00 Advanced Solid Tumors 2026-02-26
A Positron Emission Tomography (PET) study to examine the properties of a novel radioligand's suitability for imaging mutant huntingtin Recruiting

2024-515786-34-02 Huntington's disease 2026-02-24
A clinical study of MK-1045 in people with lupus or rheumatoid arthritis (MK-1045-004) Recruiting

2025-523412-36-00 Systemic lupus erythematosus, Rheumatoid arthritis 2026-02-17
To evaluate the pharmacokinetics and safety of nolasiban Recruiting

2025-523706-32-00 not applicable (submitted trial is a pharmacokinetic st 2026-02-17